They have a $25M stock sale option with MLV & CO. that will provide an additional 6 months or so of cash.
So OGXI can get into 2015 with selling these shares.
The basic rule of thumb for any biotech company is to always have 18 months of cash on hand. So one should project a shelf offering in 2014. I for one hope its after 427 results, if -011 goes down the crapper.